124I-cG250
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 124I-cG250, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma [NA]